Avita Price To Sales Ratio vs Days Of Inventory On Hand Analysis

RCEL Stock

USD 13.34 0.47 3.65%

Avita Medical financial indicator trend analysis is way more than just evaluating Avita Medical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Avita Medical is a good investment. Please check the relationship between Avita Medical Price To Sales Ratio and its Days Of Inventory On Hand accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avita Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.

Price To Sales Ratio vs Days Of Inventory On Hand

Price To Sales Ratio vs Days Of Inventory On Hand Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Avita Medical Price To Sales Ratio account and Days Of Inventory On Hand. At this time, the significance of the direction appears to have no relationship.

The correlation between Avita Medical's Price To Sales Ratio and Days Of Inventory On Hand is 0.06. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Days Of Inventory On Hand in the same time period over historical financial statements of Avita Medical, assuming nothing else is changed. The correlation between historical values of Avita Medical's Price To Sales Ratio and Days Of Inventory On Hand is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Avita Medical are associated (or correlated) with its Days Of Inventory On Hand. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Days Of Inventory On Hand has no effect on the direction of Price To Sales Ratio i.e., Avita Medical's Price To Sales Ratio and Days Of Inventory On Hand go up and down completely randomly.

Correlation Coefficient

0.06

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Avita Medical stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Avita Medical sales, a figure that is much harder to manipulate than other Avita Medical multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Days Of Inventory On Hand

Most indicators from Avita Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Avita Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avita Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.At this time, Avita Medical's Selling General Administrative is quite stable compared to the past year. Tax Provision is expected to rise to about 69.3 K this year, although the value of Sales General And Administrative To Revenue will most likely fall to 0.74.

	2021	2022	2023	2024 (projected)
Gross Profit	11.3M	41.7M	42.4M	44.5M
Total Revenue	14.3M	50.6M	50.1M	52.7M

Gross Profit Total Revenue

Avita Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Long Term Debt Total	Other Assets	Short Term Debt	Inventory	Other Current Assets	Accounts Payable	Short Term Investments	Property Plant And Equipment Net	Non Currrent Assets Other	Intangible Assets
Total Assets		0.08	0.99	0.83	-0.29	-0.97	0.53	0.89	0.86	0.87	0.82	0.51	0.85	0.64	0.99	-0.91	0.54	0.08	0.81	0.73	0.26	0.85	0.71	0.83	0.66	0.96
Other Current Liab	0.08		0.14	0.23	0.25	-0.24	-0.35	0.44	0.04	-0.03	0.04	-0.14	0.07	-0.07	0.03	0.17	-0.39	-0.25	-0.15	0.04	0.44	-0.21	0.48	-0.2	0.28	0.11
Total Current Liabilities	0.99	0.14		0.78	-0.15	-0.98	0.41	0.91	0.87	0.91	0.83	0.59	0.87	0.71	0.98	-0.87	0.43	0.03	0.76	0.81	0.34	0.8	0.79	0.8	0.75	0.94
Total Stockholder Equity	0.83	0.23	0.78		-0.59	-0.81	0.73	0.85	0.82	0.57	0.79	0.23	0.78	0.41	0.78	-0.65	0.73	-0.16	0.85	0.4	0.27	0.82	0.6	0.83	0.47	0.9
Net Debt	-0.29	0.25	-0.15	-0.59		0.19	-0.92	-0.13	-0.19	0.13	-0.25	0.4	-0.1	0.27	-0.28	0.27	-0.87	-0.09	-0.47	0.34	0.25	-0.56	0.28	-0.44	0.38	-0.34
Retained Earnings	-0.97	-0.24	-0.98	-0.81	0.19		-0.41	-0.93	-0.83	-0.84	-0.79	-0.49	-0.83	-0.62	-0.96	0.84	-0.42	-0.02	-0.73	-0.74	-0.36	-0.76	-0.78	-0.75	-0.71	-0.93
Cash	0.53	-0.35	0.41	0.73	-0.92	-0.41		0.32	0.52	0.22	0.53	-0.01	0.43	0.12	0.51	-0.48	0.98	0.0	0.75	0.02	-0.06	0.76	-0.02	0.74	-0.05	0.58
Non Current Assets Total	0.89	0.44	0.91	0.85	-0.13	-0.93	0.32		0.83	0.77	0.75	0.46	0.85	0.6	0.84	-0.71	0.35	-0.13	0.72	0.68	0.37	0.7	0.88	0.69	0.76	0.92
Cash And Short Term Investments	0.86	0.04	0.87	0.82	-0.19	-0.83	0.52	0.83		0.87	0.92	0.75	0.99	0.86	0.81	-0.7	0.56	-0.26	0.92	0.81	0.47	0.77	0.81	0.94	0.82	0.9
Net Receivables	0.87	-0.03	0.91	0.57	0.13	-0.84	0.22	0.77	0.87		0.8	0.84	0.89	0.9	0.86	-0.8	0.26	-0.04	0.7	0.94	0.34	0.7	0.82	0.77	0.86	0.84
Common Stock Shares Outstanding	0.82	0.04	0.83	0.79	-0.25	-0.79	0.53	0.75	0.92	0.8		0.63	0.88	0.76	0.77	-0.63	0.51	-0.18	0.83	0.71	0.46	0.8	0.72	0.91	0.72	0.88
Non Current Liabilities Total	0.51	-0.14	0.59	0.23	0.4	-0.49	-0.01	0.46	0.75	0.84	0.63		0.78	0.98	0.48	-0.44	0.07	-0.25	0.55	0.93	0.51	0.35	0.72	0.62	0.87	0.5
Other Stockholder Equity	0.85	0.07	0.87	0.78	-0.1	-0.83	0.43	0.85	0.99	0.89	0.88	0.78		0.88	0.8	-0.7	0.49	-0.26	0.89	0.85	0.48	0.73	0.86	0.9	0.87	0.89
Total Liab	0.64	-0.07	0.71	0.41	0.27	-0.62	0.12	0.6	0.86	0.9	0.76	0.98	0.88		0.6	-0.53	0.19	-0.27	0.67	0.95	0.55	0.48	0.8	0.74	0.92	0.64
Total Current Assets	0.99	0.03	0.98	0.78	-0.28	-0.96	0.51	0.84	0.81	0.86	0.77	0.48	0.8	0.6		-0.93	0.52	0.16	0.76	0.71	0.21	0.84	0.65	0.79	0.61	0.92
Common Stock	-0.91	0.17	-0.87	-0.65	0.27	0.84	-0.48	-0.71	-0.7	-0.8	-0.63	-0.44	-0.7	-0.53	-0.93		-0.52	-0.35	-0.73	-0.64	0.04	-0.75	-0.52	-0.7	-0.5	-0.82
Short Long Term Debt Total	0.54	-0.39	0.43	0.73	-0.87	-0.42	0.98	0.35	0.56	0.26	0.51	0.07	0.49	0.19	0.52	-0.52		0.0	0.8	0.09	-0.02	0.74	0.03	0.77	0.02	0.58
Other Assets	0.08	-0.25	0.03	-0.16	-0.09	-0.02	0.0	-0.13	-0.26	-0.04	-0.18	-0.25	-0.26	-0.27	0.16	-0.35	0.0		-0.11	-0.13	-0.38	-0.01	-0.29	-0.17	-0.3	-0.07
Short Term Debt	0.81	-0.15	0.76	0.85	-0.47	-0.73	0.75	0.72	0.92	0.7	0.83	0.55	0.89	0.67	0.76	-0.73	0.8	-0.11		0.59	0.28	0.82	0.57	0.96	0.58	0.85
Inventory	0.73	0.04	0.81	0.4	0.34	-0.74	0.02	0.68	0.81	0.94	0.71	0.93	0.85	0.95	0.71	-0.64	0.09	-0.13	0.59		0.53	0.47	0.84	0.66	0.93	0.67
Other Current Assets	0.26	0.44	0.34	0.27	0.25	-0.36	-0.06	0.37	0.47	0.34	0.46	0.51	0.48	0.55	0.21	0.04	-0.02	-0.38	0.28	0.53		0.0	0.56	0.35	0.6	0.24
Accounts Payable	0.85	-0.21	0.8	0.82	-0.56	-0.76	0.76	0.7	0.77	0.7	0.8	0.35	0.73	0.48	0.84	-0.75	0.74	-0.01	0.82	0.47	0.0		0.44	0.87	0.41	0.91
Short Term Investments	0.71	0.48	0.79	0.6	0.28	-0.78	-0.02	0.88	0.81	0.82	0.72	0.72	0.86	0.8	0.65	-0.52	0.03	-0.29	0.57	0.84	0.56	0.44		0.58	0.96	0.74
Property Plant And Equipment Net	0.83	-0.2	0.8	0.83	-0.44	-0.75	0.74	0.69	0.94	0.77	0.91	0.62	0.9	0.74	0.79	-0.7	0.77	-0.17	0.96	0.66	0.35	0.87	0.58		0.61	0.87
Non Currrent Assets Other	0.66	0.28	0.75	0.47	0.38	-0.71	-0.05	0.76	0.82	0.86	0.72	0.87	0.87	0.92	0.61	-0.5	0.02	-0.3	0.58	0.93	0.6	0.41	0.96	0.61		0.67
Intangible Assets	0.96	0.11	0.94	0.9	-0.34	-0.93	0.58	0.92	0.9	0.84	0.88	0.5	0.89	0.64	0.92	-0.82	0.58	-0.07	0.85	0.67	0.24	0.91	0.74	0.87	0.67

Click cells to compare fundamentals

Avita Medical Account Relationship Matchups

Avita Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Other Current Liab	455.5K	(1.4M)	(957K)	6.9M	338K	321.1K
Total Current Liabilities	4.4M	11.2M	7.7M	15.7M	13.2M	13.9M
Retained Earnings	(128.7M)	(282.4M)	(194.9M)	(385.7M)	(298.0M)	(283.1M)
Net Receivables	2.1M	3.5M	2.4M	5.2M	7.7M	8.0M
Other Stockholder Equity	29.8M	375.5M	259.2M	499.2M	574.0M	602.7M
Total Current Assets	24.2M	113.6M	78.4M	128.5M	104.0M	109.2M
Inventory	740.8K	1.6M	1.1M	3.1M	5.6M	5.9M
Other Current Assets	1.1M	1.7M	990K	3.6M	4.2M	4.4M
Accounts Payable	3.9M	6.3M	4.3M	4.4M	3.8M	4.0M
Other Liab	471K	435K	1.6M	2.5M	2.9M	3.0M
Net Tangible Assets	20.6M	72.0M	115.2M	84.3M	96.9M	51.6M
Property Plant Equipment	1.3M	3.7M	2.9M	2.1M	2.4M	1.7M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Avita Medical is a strong investment it is important to analyze Avita Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avita Medical's future performance. For an informed investment choice regarding Avita Stock, refer to the following important reports:

How To Invest In Avita

Details

Is Avita Stock a good investment?

Details

What is Avita Medical's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avita Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.

You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. If investors know Avita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avita Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.23)

Revenue Per Share

2.335

Quarterly Revenue Growth

0.432

Return On Assets

(0.45)

Return On Equity

(1.52)

The market value of Avita Medical is measured differently than its book value, which is the value of Avita that is recorded on the company's balance sheet. Investors also form their own opinion of Avita Medical's value that differs from its market value or its book value, called intrinsic value, which is Avita Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avita Medical's market value can be influenced by many factors that don't directly affect Avita Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Avita Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avita Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avita Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Avita Price To Sales Ratio vs Days Of Inventory On Hand Analysis

Price To Sales Ratio vs Days Of Inventory On Hand

Price To Sales Ratio vs Days Of Inventory On Hand Correlation Analysis

Correlation Coefficient

Price To Sales Ratio

Days Of Inventory On Hand

Avita Medical fundamental ratios Correlations

Avita Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Avita Medical fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Other Stockholder Equity	+ 0.99	Cash And Short Term Investments
Total Current Assets	+ 0.98	Total Current Liabilities
Short Long Term Debt Total	+ 0.98	Cash
Total Liab	+ 0.98	Non Current Liabilities Total

Retained Earnings	- 0.98	Total Current Liabilities
Retained Earnings	- 0.97	Total Assets
Total Current Assets	- 0.96	Retained Earnings
Common Stock	- 0.93	Total Current Assets
Intangible Assets	- 0.93	Retained Earnings
Non Current Assets Total	- 0.93	Retained Earnings